This multicenter study, which included benign melanoses and cases that had progressed to melanoma, was undertaken using a digital platform, where each case had a H&E section with accompanying Melan-A, SOX10, and PRAME (PReferentially expressed Antigen of MElanoma) immunostains and associated clinical information, simulating the usual diagnostic scenario. Here, PRAME is linked to melanoma.